Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA’s Center for Drug Evaluation and Research Janet Woodcock, M.D., on the FDA’s continuing efforts to maintain its strong oversight of generic drug quality issues domestically and abroad - FDA Press Releases

FDA outlines continuing efforts to maintain its strong oversight of generic drug quality issues domestically and abroad

from Food and Drug Administration--Press Releases https://ift.tt/2XjWJhN
via IFTTT